(Q45983340)

English

Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation.

scientific article published on 3 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

1 reference

based on heuristic

inferred from title

nephrotic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

object named as

Michal Malina

1

0 references

author name string

Jan Janda

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

Tomas Seeman

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

publication date

3 June 2009

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

Pediatric Nephrology

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

24

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

10

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

2051-2053

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

https://scigraph.springernature.com/pub.10.1007/s00467-009-1211-0

0 references

Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin therapy in patients with Alport syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of cyclosporine A in Alport's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WT1 and NPHS2 mutations in Korean children with steroid-resistant nephrotic syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interventions for idiopathic steroid-resistant nephrotic syndrome in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19495806

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00467-009-1211-0

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/19495806

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45983340&oldid=1713926552"